Comments on: AvandiaGate: A Few Opening Remarks http://www.pharmalot.com/2007/06/avandiagate-a-few-opening-remarks/ News, Comment and Conversation Sun, 21 Mar 2010 01:32:23 +0000 http://wordpress.org/?v=2.6.2 By: More on Avandia: Why We Need to “Call Off the Dogs” | Etixet Tag Cloud Archive 10.000 Web Site Feed http://www.pharmalot.com/2007/06/avandiagate-a-few-opening-remarks/#comment-83324 More on Avandia: Why We Need to “Call Off the Dogs” | Etixet Tag Cloud Archive 10.000 Web Site Feed Mon, 07 Jan 2008 14:24:16 +0000 http://www.pharmalot.com/2007/06/avandiagate-a-few-opening-remarks/#comment-83324 [...] - Pharmalot has links to many documents used in the Congressional hearing here. Share and Enjoy:These icons link to social bookmarking sites where readers can share and discover [...] [...] - Pharmalot has links to many documents used in the Congressional hearing here. Share and Enjoy:These icons link to social bookmarking sites where readers can share and discover [...]

]]> By: Hank http://www.pharmalot.com/2007/06/avandiagate-a-few-opening-remarks/#comment-3702 Hank Wed, 06 Jun 2007 20:20:07 +0000 http://www.pharmalot.com/2007/06/avandiagate-a-few-opening-remarks/#comment-3702 Yikes. Watched most of the "hearing," although I'm not sure much "hearing" was going on. I am left wondering if rational discussion of these issues - not only Avandia, but FDA reform and the relationships between industry and research - is even possible. Maybe I haven't watched enough of these "hearings" to develop the requisite immunity from hope. From a purely "dramatic" point of view, Buse is no whistleblower, but the gray area in which he has found, and put, himself makes it more interesting as a human story. What I really wonder is this: How often do researchers genuinely "cave" under threats? In particular, junior people trying to establish themselves? And how typical is this sort of "vigorous scientific debate" (i.e., you owe us $4 billion)? I have heard a lot of "war stories" from researchers, many pretty hair-raising. But still I wonder what is normative. Yikes. Watched most of the “hearing,” although I’m not sure much “hearing” was going on. I am left wondering if rational discussion of these issues - not only Avandia, but FDA reform and the relationships between industry and research - is even possible. Maybe I haven’t watched enough of these “hearings” to develop the requisite immunity from hope.

From a purely “dramatic” point of view, Buse is no whistleblower, but the gray area in which he has found, and put, himself makes it more interesting as a human story. What I really wonder is this: How often do researchers genuinely “cave” under threats? In particular, junior people trying to establish themselves? And how typical is this sort of “vigorous scientific debate” (i.e., you owe us $4 billion)?

I have heard a lot of “war stories” from researchers, many pretty hair-raising. But still I wonder what is normative.

]]> By: Insider http://www.pharmalot.com/2007/06/avandiagate-a-few-opening-remarks/#comment-3692 Insider Wed, 06 Jun 2007 15:47:35 +0000 http://www.pharmalot.com/2007/06/avandiagate-a-few-opening-remarks/#comment-3692 Thanks for the link. Excellent! Thanks for the link.

Excellent!

]]>